2023
DOI: 10.1039/d2nr05920g
|View full text |Cite
|
Sign up to set email alerts
|

Bioorthogonal nanozymes: an emerging strategy for disease therapy

Zheao Zhang,
Kelong Fan

Abstract: Transition metal catalysts (TMCs), capable of performing bioorthogonal reactions, have been engineered to trigger the formation of bioactive molecules in a controlled manner for biomedical applications. However, the widespread use...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 87 publications
0
9
0
Order By: Relevance
“…Incorporating click chemistry reaction sites on the surface of the nanozyme to achieve bioconjugation and construct asymmetric structures provides an elegant means to modulate remaining substrate interactions. [ 296 ] By leveraging these strategies, researchers can continue to refine the performance of Co‐based nanozymes and unlock their full potential in sensing and detection applications. [ 297 ]…”
Section: Discussionmentioning
confidence: 99%
“…Incorporating click chemistry reaction sites on the surface of the nanozyme to achieve bioconjugation and construct asymmetric structures provides an elegant means to modulate remaining substrate interactions. [ 296 ] By leveraging these strategies, researchers can continue to refine the performance of Co‐based nanozymes and unlock their full potential in sensing and detection applications. [ 297 ]…”
Section: Discussionmentioning
confidence: 99%
“…A variety of nanoparticle scaffolds can be used to encapsulate TMCs, including silica nanoparticles (SiONPs), gold nanoparticles (AuNPs), metal‐organic frameworks (MOFs), polymeric nanoparticles, and resin nanoparticles ( Table 1 ). [ 59 ] Each of these scaffolds provides unique features for the resulting nanozyme. SiONPs are stable under physiological conditions and different pHs, but they possess low biocompatibility.…”
Section: Step 2: Choosing the Nanoscaffoldmentioning
confidence: 99%
“…Such nanoparticles can be classified to the group of so-called bioorthogonal nanozymes, nanomaterials with enzyme-like properties. 7,53 The nanomaterial scaffolds not only solubilize the catalysts in water, but also protect them from deactivating components in living cells and minimize overall cytotoxicity. They allow substrate accumulation near the catalyst site by the "concentrator effect", 54 enhancing the reaction rate at low concentrations.…”
Section: Introductionmentioning
confidence: 99%